A widely used sugar substitute, xylitol, is linked to a significantly higher risk of major cardiovascular events, including heart attack and stroke, according to research presented at the European Society of Cardiology Congress in Germany. Researchers analyzed health data from more than 17,700 participants across two large studies.
People who consume greater amounts of xylitol could face a heightened threat of serious heart problems, a newly presented study suggests. Researchers shared the findings at the European Society of Cardiology Congress, drawing attention to a sugar alcohol commonly added to everyday items like chewing gum, toothpaste, baked goods, and oral care products.
Canadian and British Cohort Findings on Cardiovascular Events
The research evaluated data from 17,700 participants drawn from two major, long-running observational groups: the Canadian Longitudinal Study on Aging (reported by USA Today) and the European Prospective Investigation into Cancer, or EPIC, Norfolk cohort in the United Kingdom (noted by ibtimes.com.au).
Over a six-year follow-up period, Canadian participants with the highest blood levels of xylitol exhibited a 57% higher risk of major adverse cardiovascular events—defined as death, myocardial infarction, or stroke—when compared to individuals with the lowest levels (detailed by Fox News). In the British cohort, which was tracked over a much longer 30-year span, participants in the highest xylitol quartile showed an 18% greater risk of cardiovascular incidents (covered by ynetnews.com).
Investigators observed a dose-dependent relationship across both groups. As blood concentrations of xylitol increased, the corresponding rate of cardiovascular events climbed as well (according to wesh.com). These elevated risks persisted even after researchers adjusted for traditional risk factors such as age, sex, body mass index, smoking status, hypertension, diabetes, and cholesterol levels (reported by thenews.com.pk).
Charité University Hospital Research and Blood Clotting Mechanisms
The newly presented data builds upon prior scientific investigations into how sugar alcohols interact with human biology. Dr. Marco Witkowski, from Charité University Hospital in Berlin who presented the findings at the congress, explained that earlier laboratory and clinical work by his team demonstrated how the sweetener affects blood components (noted by gizmodo.com).
“In previous studies, we showed that xylitol can enhance the ability of platelets to form clots.”
Dr. Marco Witkowski, Charité University Hospital
Researchers emphasized that because the investigation was observational, it establishes an association rather than a definitive cause-and-effect relationship (reported by USA Today). Furthermore, high blood xylitol levels do not exclusively reflect dietary intake, as the human body can naturally produce the compound during glucose metabolism (noted by Fox News).
Regulatory Standing and Expert Reaction
Artificial sweeteners are widely consumed by individuals seeking alternatives to sugar and maintain safety approvals from regulatory bodies (reported by Fox News).
“Our long-term findings in the general population highlight how little we know about the cardiovascular safety of xylitol and indicate that further studies are warranted, especially as the amount of xylitol in products continues to increase.”
Dr. Marco Witkowski, presenter from Charité University Hospital
Dan Atar, professor and member of the ESC Communication Committee, acknowledged the regulatory history while supporting calls for additional research into long-term public health impacts (noted by USA Today).
“Artificial sweeteners are widely embraced by modern society, and the safety ratings had been good and granted by regulatory authorities. In this observational work, however, it appears that xylitol has a negative long-term effect on cardiovascular events in the general population.”
Dan Atar, European Society of Cardiology Communication Committee
Because the congress presentation has not yet undergone formal peer review as a published journal article, scientific and medical communities continue to evaluate the implications of the data as further studies are planned (noted by gizmodo.com).
Keep reading